FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step The Peptide Boom Is Getting Out of Hand The Atlantic FDA's Overreach on Compounded Peptides FDA to weigh easing limits on unproven peptides promoted by RFK Jr.